Top Markets
Coin of the day
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited

0950
株式のランク #22620
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops,... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
株価
$0.1458359
最終同期: 2026-08-21
時価総額
$85.87M
変化(1日)
-1.30%
変化(1年)
-38.40%
HK
取引 Lee's Pharmaceutical Holdings Limited (0950)

カテゴリー

Bの時価総額の0950の価格
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
0950
$0.1458359
の時価総額 Lee's Pharmaceutical Holdings Limited(0950)
時価総額: $85.87M
August 2026時点で、Lee's Pharmaceutical Holdings Limited の時価総額は $85.87M です。これは、当社のデータによると、Lee's Pharmaceutical Holdings Limited が世界で22620th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Lee's Pharmaceutical Holdings Limited の時価総額の履歴(2002 から 2026 まで)
0950最も人気のあるトップ5と比較stocks
0950の価格 資産b bの市場 結果
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$8,850.34 $85.87M
$5.211T +6,068,594.72%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,721.62 $85.87M
$4.547T +5,294,634.25%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,069.03 $85.87M
$4.162T +4,847,147.71%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$6,101.55 $85.87M
$3.593T +4,183,743.16%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$4,743.03 $85.87M
$2.793T +3,252,208.68%